Patents by Inventor Andrzej Konieczny

Andrzej Konieczny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10677092
    Abstract: A turbomachine structure having a first inner casing including a first and second flowpath oriented in opposing axial directions to one another; a second inner casing surrounding the first inner casing and including a third and fourth flowpath, wherein the third flowpath is fluidly connected to the first flowpath and the fourth flowpath is fluidly connected to the second flowpath; an extraction chamber defined between the first and second inner casings; a cooling passage defined between the first and second inner casings; a first extraction port fluidly connected to the cooling passage and to the first flowpath at a location in the first flowpath having a first pressure; and a second extraction port fluidly connected to the extraction chamber and to the second flowpath at a location in the second flowpath having a second pressure less than the first pressure.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: June 9, 2020
    Assignee: General Electric Company
    Inventors: Rolf Döbler, Paolo Capozzi, Andrzej Konieczny
  • Publication number: 20200131930
    Abstract: A turbomachine structure having a first inner casing including a first and second flowpath oriented in opposing axial directions to one another; a second inner casing surrounding the first inner casing and including a third and fourth flowpath, wherein the third flowpath is fluidly connected to the first flowpath and the fourth flowpath is fluidly connected to the second flowpath; an extraction chamber defined between the first and second inner casings; a cooling passage defined between the first and second inner casings; a first extraction port fluidly connected to the cooling passage and to the first flowpath at a location in the first flowpath having a first pressure; and a second extraction port fluidly connected to the extraction chamber and to the second flowpath at a location in the second flowpath having a second pressure less than the first pressure.
    Type: Application
    Filed: October 26, 2018
    Publication date: April 30, 2020
    Inventors: Rolf Döbler, Paolo Capozzi, Andrzej Konieczny
  • Publication number: 20170067368
    Abstract: The embodiments relate to a steam turbine with modular inserts that are removably insertable into an inner case. The modular inserts include a seal carrier modular insert located towards a first end of the steam turbine, for carrier seals located between the inner casing the rotor, that is cylindrically shaped and removably insertable into the inner casing, an inlet spiral insert, adjacent the seal carrier modular insert and removably insertable into the inner casing, for introducing steam into the steam expansion flow path so as to circumferentially distribute steam feed into the steam turbine; and a blade carrier modular insert, adjacent the inlet spiral insert, that is also cylindrically shaped and removably insertable into the inner casing, for retaining stationary blades.
    Type: Application
    Filed: September 6, 2016
    Publication date: March 9, 2017
    Inventors: ALAIN DENIS MALAGUTI LARRAZABAL, SILVIA GAFNER, THOMAS SCHREIER, MIRKO RUEDI MEIER, ANDRZEJ KONIECZNY
  • Patent number: 7961571
    Abstract: A recording method, particularly suitable for use in a digital video-camera, is described according to which a digital signal (10), deriving from the encoding of an audio-video signal is temporarily stored in a buffer (11) and from there recorded in a dual layer DVD (12) in successive recording intervals (22) or packets. The start/stop of a recording interval is normally controlled according to the level (15) of filling of the buffer. The digital signal is partitioned in portions that need to be entirely recorded on one single layer, and this triggers the need for a layer jump independently from the level of filling of the buffer. In order to avoid starting a layer jump with the buffer already partly filled, and therefore having a short non-recording interval (23) when time is mostly needed for calibrations, it is proposed to adjust the resolution in the encoding of the audio-video signal so as to have the buffer close to empty when the layer jump occurs.
    Type: Grant
    Filed: July 7, 2006
    Date of Patent: June 14, 2011
    Assignee: Koninklijke Philips Electronics N.V.
    Inventor: Pawel Andrzej Konieczny
  • Patent number: 7666441
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Can f I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of petides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: February 23, 2010
    Assignee: Merck Patent GmbH
    Inventors: Jay P. Morgenstern, Christine Bizinkauskas, Andrzej Konieczny, Andrew W. Brauer
  • Publication number: 20080205217
    Abstract: A recording method, particularly suitable for use in a digital video-camera, is described according to which a digital signal (10), deriving from the encoding of an audio-video signal is temporarily stored in a buffer (11) and from there recorded in a dual layer DVD (12) in successive recording intervals (22) or packets. The start/stop of a recording interval is normally controlled according to the level (15) of filling of the buffer. The digital signal is partitioned in portions that need to be entirely recorded on one single layer, and this triggers the need for a layer jump independently from the level of filling of the buffer. In order to avoid starting a layer jump with the buffer already partly filled, and therefore having a short non-recording interval (23) when time is mostly needed for calibrations, it is proposed to adjust the resolution in the encoding of the audio-video signal so as to have the buffer close to empty when the layer jump occurs.
    Type: Application
    Filed: July 7, 2006
    Publication date: August 28, 2008
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS, N.V.
    Inventor: Pawel Andrzej Konieczny
  • Publication number: 20080205234
    Abstract: A recording method, particularly suitable for use in a digital video-camera, is described according to which a digital signal (10), deriving from the encoding of an audio-video signal is temporarily stored in a buffer (11) and from there recorded on a dual layer DVD (12). The need for a layer jump occurs, independently from the current level of filling of the buffer, when a storage space associated to a first layer has been exhausted. In order to be able to store the digital signal in the buffer while the layer jump is accomplished, it is proposed to decrease the resolution in the encoding of the audio-video signal, so as to have the level in the buffer growing relatively slowly when the layer jump occurs.
    Type: Application
    Filed: July 7, 2006
    Publication date: August 28, 2008
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS, N.V.
    Inventor: Pawel Andrzej Konieczny
  • Publication number: 20070202132
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Can f I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of petides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Application
    Filed: December 12, 2006
    Publication date: August 30, 2007
    Applicant: HESKA CORPORATION
    Inventors: Jay Morgenstern, Christine Bizinkauskas, Andrzej Konieczny, Andrew Brauer
  • Patent number: 7166291
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Can fI or Can fII. are disclosed. A cDNA encoding a peptide having a Can fI activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can fII activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can fI or Can fII nucleic acid in a sample or for the recombinant production of petides having a Can fI or Can fII activity. Peptides having a Can fI or Can fII activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Grant
    Filed: August 12, 2005
    Date of Patent: January 23, 2007
    Assignee: Heska Corporation
    Inventors: Jay P. Morgenstern, Christine B. Bizinkauskas, Andrzej Konieczny, Andrew W. Brauer
  • Patent number: 7026128
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Can f I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of peptides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: April 11, 2006
    Assignee: Heska Corporation
    Inventors: Jay P. Morgenstern, Christine B. Bizinkauskas, Andrzej Konieczny, Andrew W. Brauer
  • Publication number: 20060057641
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Canf I or Can f II. are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of petides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Application
    Filed: August 12, 2005
    Publication date: March 16, 2006
    Applicant: IMMULOGIC PHARMACEUTICAL CORP.
    Inventors: Jay Morgenstern, Christine Bizinkauskas, Andrzej Konieczny, Andrew Brauer
  • Publication number: 20030049691
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Can f I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of peptides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Application
    Filed: July 16, 2002
    Publication date: March 13, 2003
    Inventors: Jay P. Morgenstern, Christine Bizinkauskas, Andrzej Konieczny, Andrew W. Brauer
  • Patent number: 6489118
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Canf I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of petides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: December 3, 2002
    Assignee: ImmuLogic Pharmaceutical Corporation
    Inventors: Jay P. Morgenstern, Christine B. Bizinkauskas, Andrzej Konieczny, Andrew W. Brauer
  • Publication number: 20020012963
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Canf I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of petides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Application
    Filed: August 16, 1999
    Publication date: January 31, 2002
    Applicant: ImmuLogic Pharmaceutical Corporation
    Inventors: JAY P. MORGENSTERN, CHRISTINE B. BIZINKAUSKAS, ANDRZEJ KONIECZNY, ANDREW W. BRAUER
  • Patent number: 5891716
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Can f I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of petides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: April 6, 1999
    Assignee: ImmuLogic Pharmaceutical Corporation
    Inventors: Jay P. Morgenstern, Andrzej Konieczny, Christine B. Bizinkauskas, Andrew W. Brauer
  • Patent number: 5843672
    Abstract: Isolated nucleic acids encoding allergens of Canis familiaris, Can f I or Can f II, are disclosed. A cDNA encoding a peptide having a Can f I activity and a predicted molecular weight of about 19,200 daltons is also described. A cDNA encoding a peptide having Can f II activity and a predicted molecular weight of about 18,200 daltons is also disclosed. The nucleic acids can be used as probes to detect the presence of Can f I or Can f II nucleic acid in a sample or for the recombinant production of peptides having a Can f I or Can f II activity. Peptides having a Can f I or Can f II activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 1, 1998
    Assignee: ImmuLogic Pharmaceutical Corporation
    Inventors: Jay P. Morgenstern, Andrzej Konieczny, Christine B. Bizinkauskas, Andrew W. Brauer